Breaking News on Drug DiscoveryDaily
Thursday 18 October 2007
Forward to a colleague |
|
|
| Breaking News on Drug Discovery |
||
|
||
| Daily
Thursday 18 October 2007 |
Forward to a colleague |
|
|
Access Full Stories  Pfizer abandons ship as Exubera sinksPfizer revealed today that it is abandoning its once-touted blockbuster Exubera, ending months of speculation as to whether the fledging world-first inhalable insulin would sink or swim in the fierce waters of... Read Novartis suffers from generics, cuts jobs Novartis has turned in its results for the first nine months of the year, with income gnawed at by generic competition and product suspensions, but still claiming record earnings helped along by divestment gains... Read BioXell says 'ciao' to enlarged prostates As men grow older, the majority of them will suffer from the symptoms of an enlarged prostate. However, help could be on the horizon from BioXell's new drug that treats both the symptoms and, crucially, the cause... Read Agilent and BioTrove push discovery efficiency Agilent and BioTrove are collaborating to deliver ultra high-throughput sample preparation and mass spectrometry (MS) systems to speed the analysis of in vitro assays used in drug development... Read Online drug discovery services database to be launched A US start-up firm is gearing up to launch an online database where researchers can access a variety of drug discovery service providers across the globe... Read |
|
||||||||||||||||
All News Headlines for: October | September | August |
||||||||||||||||||
 Technical / White PaperManufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here | ||||||||||||||||||
|
||||||||||||||||||
|
Related Industry News Next gen cancer prodrug to challenge Pfizer's Camptosar French firm Diatos has created a second generation irinotecan cancer therapy using its patented peptide-based drug delivery system, coming up with a drug that has greatly improved efficacy and safety profile compared... Read Guarding against the misuse of synthetic genomics A new report has outlined a series of recommendations for government policymakers to help mitigate the potential risks of the burgeoning synthetic genomics area... Read Fingerprinting the structure of pharmaceuticals A new solid-state proton NMR (nuclear magnetic resonance) technique has been developed that can quickly determine polymorphism of active pharmaceuticals within tablet formulations... Read Galenica acquires Aspreva Swiss pharmaceutical and logistics company Galenica is to acquire Canadian pharmaceutical company Aspreva Pharmaceuticals for $915m (€645.2m)... Read
|
||||||||||||||||||
|
|
|
|||
| Forward to a colleague |
|||||
|
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
|
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||
